Based In Bethlehempa Levolta Pharmaceuticals Features A Portfolio Of Early Stage Small Molecules And Late Stage Novel Formulated Compounds For Rheumatologythe Central Nervous Systemoncology And Immunologywhich The Company Obtained Through The Acquisitions Of Imc Biotechnology And Renascense Pharmaceuticalsthe Portfolio Is Designed To Overcome Current Treatment Barriers Through An Enhanced Therapeutic Index That Drives Customer Valueit S Lead Productvolt01Is A Reformulated Zoledronic Acidzathat Has Demonstrated Significantly Better Safety And Efficacy In Controlling Knee Osteoarthritis Compared To Za Alonewith The Added Benefit Of No Post Dosing Symptomsvolt01 Has The Potential To Be The First Disease Modifying Drugdmardfor Osteoarthritis For More Informationplease Call848702 0682 Or Visit Www Levoltapharma Com
